Skip to content

Comparative Evaluation of Two Different Formulations of Xylitol used in children with early childhood caries to see the effect on Streptococcus mutans and Candida albicans

Comparative Evaluation of Two Different Formulations of Xylitol on Streptococcus mutans and Candida albicans in Children with Early Childhood Caries: A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072642
Enrollment
44
Registered
2024-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K029- Dental caries, unspecified

Interventions

Intervention1: Xylitol Wipes and Xylitol Toothpaste: The intervention is done for 1 month after the enrollment of children with early childhood caries at the time of baseline. Control Intervention1: F

Sponsors

Dr Simran Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children aged 3-6 years. 2. Children with ECC, as per AAPD criteria 3. ASA I 4. Frankl Rating 3 & 4 5. Subjects willing to comply with the study protocol.

Exclusion criteria

Exclusion criteria: 1. Children with systemic diseases or history of recent hospitalization 2. Consumption of antibiotics in the last 3 months. 3. Children who have previously used xylitol products regularly within the last 3 months. 4. Children lacking cooperative ability.

Design outcomes

Primary

MeasureTime frame
To check the reduction in colony counts of Streptococcus Mutans and Candida AlbicansTimepoint: The outcome will be assessed at baseline, at 1 month and 2 months

Secondary

MeasureTime frame
To check the reduction in plaque accumulationTimepoint: It will be assessed at baseline and at 1 month

Countries

India

Contacts

Public ContactDr Simran Singh

ITS Dental College, Hospital and Research Centre,47 Knowledge Park, Greater Noida

mousumi87goswami@gmail.com8588854190

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026